Evidence map›Paper›PMID 24256728›Full record

ArticleNature2014

Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.

Bi-Sen Ding, Zhongwei Cao, Raphael Lis, Daniel J Nolan, Peipei Guo, Michael Simons, Mark E Penfold, Koji Shido, Sina Y Rabbany, Shahin Rafii

Open access · greenAbstract read
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 359 papers.

0numbers the graph read from it
0cells of the map it votes in
359citing papers in PubMed
21.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

359 citing papers in PubMed, 614 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
  20. Article

299 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Bi-Sen Ding1] Ansary Stem Cell Institute, Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York 10065, USA [2].
Zhongwei Cao1] Ansary Stem Cell Institute, Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York 10065, USA [2].
Raphael LisAnsary Stem Cell Institute, Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York 10065, USA.
Daniel J Nolan1] Ansary Stem Cell Institute, Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York 10065, USA [2] Angiocrine Bioscience, New York, New York 10065, USA.
Peipei GuoAnsary Stem Cell Institute, Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York 10065, USA.
Michael SimonsYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Mark E PenfoldChemoCentryx, Inc., Mountain View, California 94043, USA.
Koji ShidoAnsary Stem Cell Institute, Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York 10065, USA.
Sina Y Rabbany1] Ansary Stem Cell Institute, Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York 10065, USA [2] Bioengineering Program, Hofstra University, Hempstead, New York 11549, USA.
Shahin RafiiAnsary Stem Cell Institute, Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York 10065, USA.
Cornell University · USHoward Hughes Medical Institute · USChemoCentryx (United States) · USHofstra University · USYale University · US

Funding

Angiogensis and ischemiaR01HL053793 · NHLBI · YALE UNIVERSITY · PI SIMONS, MICHAEL · 1996 to 2017
$7.3M
The Proneural Perivascular Niche and Therapeutic ResponseU54CA163167 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI HUSE, JASON · 2011 to 2015
$4.6M
Dynamic regulation of the epigenome during hematopoietic differntiationRC2HL101846 · NHLBI · COLD SPRING HARBOR LABORATORY · PI GINGERAS, THOMAS RAYMOND, HANNON, GREGORY J · 2009 to 2010
$2.5M
Identification of vascular-derived signals for alveolar lung repairR01HL119872 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI RAFII, SHAHIN · 2013 to 2016
$2.3M
Identification of vascular inductive signals in liver regenerationR01DK095039 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI RAFII, SHAHIN · 2012 to 2016
$2.2M
Contribution of the vascular niche to the hematopoietic reconstitution.R01HL097797 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI RAFII, SHAHIN · 2009 to 2012
$1.7M
Howard Hughes Medical InstituteNCI NIH HHS U54CA163167NHLBI NIH HHS R01 HL053793NHLBI NIH HHS R01 HL097797NHLBI NIH HHS R01HL097797NHLBI NIH HHS R01 HL119872NHLBI NIH HHS R01HL119872NHLBI NIH HHS RC2 HL101846NHLBI NIH HHS RC2HL101846NIDDK NIH HHS R01 DK095039NIDDK NIH HHS R01DK095039
6 · The paper itself

Abstract

Chemical or traumatic damage to the liver is frequently associated with aberrant healing (fibrosis) that overrides liver regeneration. The mechanism by which hepatic niche cells differentially modulate regeneration and fibrosis during liver repair remains to be defined. Hepatic vascular niche predominantly represented by liver sinusoidal endothelial cells deploys paracrine trophogens, known as angiocrine factors, to stimulate regeneration. Nevertheless, it is not known how pro-regenerative angiocrine signals from liver sinusoidal endothelial cells is subverted to promote fibrosis. Here, by combining an inducible endothelial-cell-specific mouse gene deletion strategy and complementary models of acute and chronic liver injury, we show that divergent angiocrine signals from liver sinusoidal endothelial cells stimulate regeneration after immediate injury and provoke fibrosis after chronic insult. The pro-fibrotic transition of vascular niche results from differential expression of stromal-derived factor-1 receptors, CXCR7 and CXCR4 (refs 18, 19, 20, 21), in liver sinusoidal endothelial cells. After acute injury, CXCR7 upregulation in liver sinusoidal endothelial cells acts with CXCR4 to induce transcription factor Id1, deploying pro-regenerative angiocrine factors and triggering regeneration. Inducible deletion of Cxcr7 in sinusoidal endothelial cells (Cxcr7(iΔEC/iΔEC)) from the adult mouse liver impaired liver regeneration by diminishing Id1-mediated production of angiocrine factors. By contrast, after chronic injury inflicted by iterative hepatotoxin (carbon tetrachloride) injection and bile duct ligation, constitutive FGFR1 signalling in liver sinusoidal endothelial cells counterbalanced CXCR7-dependent pro-regenerative response and augmented CXCR4 expression. This predominance of CXCR4 over CXCR7 expression shifted angiocrine response of liver sinusoidal endothelial cells, stimulating proliferation of desmin(+) hepatic stellate-like cells and enforcing a pro-fibrotic vascular niche. Endothelial-cell-specific ablation of either Fgfr1 (Fgfr1(iΔEC/iΔEC)) or Cxcr4 (Cxcr4(iΔEC/iΔEC)) in mice restored the pro-regenerative pathway and prevented FGFR1-mediated maladaptive subversion of angiocrine factors. Similarly, selective CXCR7 activation in liver sinusoidal endothelial cells abrogated fibrogenesis. Thus, we demonstrate that in response to liver injury, differential recruitment of pro-regenerative CXCR7-Id1 versus pro-fibrotic FGFR1-CXCR4 angiocrine pathways in vascular niche balances regeneration and fibrosis. These results provide a therapeutic roadmap to achieve hepatic regeneration without provoking fibrosis.

Indexed as

Signal TransductionAcute DiseaseAnimalsBile DuctsCarbon TetrachlorideChemical and Drug Induced Liver Injury, ChronicChemokine CXCL12Chronic DiseaseDisease Models, AnimalEndothelial CellsLigationLiver CirrhosisLiver RegenerationMiceReceptor, Fibroblast Growth Factor, Type 1Receptors, CXCRCarbon TetrachlorideChemokine CXCL12Cmkor1 protein, mouseCxcl12 protein, mouseCXCR4 protein, mouseFgfr1 protein, mouseReceptor, Fibroblast Growth Factor, Type 1Receptors, CXCRReceptors, CXCR4

Identifiers

PMID24256728
PMCPMC4142699
OpenAlexW1997695335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.